Key Takeaways
- • LifeStance Health (LFST) stock has roughly doubled this year, outpacing telehealth peers Teladoc Health (TDOC), Hims & Hers Health (HIMS) and Doximity (DOCS), according to Investor's Business Daily.
- • The behavioral health services company was built rollup-style through about 100 acquisitions and private-equity backing.
- • LifeStance is now delivering double-digit revenue growth and clinician additions, with some organic growth, per the report.
Summary
The behavioral health services provider was assembled largely through a rollup strategy, executing about 100 acquisitions with private-equity backing. That model has supported its expansion into a larger national network of mental health clinicians.
According to the report, the company is now delivering double-digit revenue growth and clinician additions, with some of that growth coming organically rather than solely from acquisitions. The source article's summary is brief, so further details on financial metrics, valuation, and forward guidance are not available from this coverage.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.